Capricor Therapeutics Inc (CAPR)
5.15
+0.11
(+2.18%)
USD |
NASDAQ |
Apr 25, 16:00
5.146
0.00 (0.00%)
After-Hours: 20:00
Capricor Therapeutics Revenue (TTM): 25.18M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 25.18M |
September 30, 2023 | 14.05M |
June 30, 2023 | 9.456M |
March 31, 2023 | |
December 31, 2022 | |
September 30, 2022 | |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | 0.3196M |
March 31, 2021 | 0.1654M |
December 31, 2020 | 0.3103M |
September 30, 2020 | 0.4745M |
June 30, 2020 | 0.5997M |
March 31, 2020 | 0.9602M |
December 31, 2019 | 1.005M |
September 30, 2019 | 1.431M |
June 30, 2019 | 1.508M |
March 31, 2019 | 1.502M |
December 31, 2018 | 1.671M |
September 30, 2018 | 1.499M |
June 30, 2018 | 1.593M |
March 31, 2018 | 2.186M |
Date | Value |
---|---|
December 31, 2017 | 2.666M |
September 30, 2017 | 2.874M |
June 30, 2017 | 3.244M |
March 31, 2017 | 3.160M |
December 31, 2016 | 3.190M |
September 30, 2016 | 3.418M |
June 30, 2016 | 3.646M |
March 31, 2016 | 3.646M |
December 31, 2015 | 3.776M |
September 30, 2015 | 3.906M |
June 30, 2015 | 4.036M |
March 31, 2015 | 4.167M |
December 31, 2014 | 4.167M |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | 1.55M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.1654M
Minimum
Mar 2021
25.18M
Maximum
Dec 2023
4.622M
Average
0.9826M
Median
Revenue (TTM) Benchmarks
Cutera Inc | 230.18M |
Sarepta Therapeutics Inc | 1.243B |
PTC Therapeutics Inc | 937.82M |
Solid Biosciences Inc | -- |
AIM ImmunoTech Inc | 0.202M |